MENU
PHAT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Phathom Pharmaceuticals (PHAT) Earnings Date & Reports
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more
A.I. Advisor
published Earnings
PHAT is expected to report earnings to rise 13.22% to -20 cents per share on August 06
Q2'26
Est.
$-0.20
Q1'26
Beat
by $0.09
Q4'25
Beat
by $0.34
Q3'25
Beat
by $0.32
Q2'25
Beat
by $0.12
The last earnings report on April 30 showed earnings per share of -18 cents, beating the estimate of -27 cents. With 246.35K shares outstanding, the current market capitalization sits at 852.59M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders
Industry Biotechnology
Profile
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
371
Web
https://www.phathompharma.com